Daniel Sullivan
President and CEO
Daniel Sullivan is a veteran entrepreneur and leader in the medical technology industry in Minneapolis, Minn. Previously, he served simultaneous roles as general manager, Ancillary Division and vice president, sales and marketing, at SCIMED Life Systems, which was purchased by Boston Scientific Corporation in 1995 for over $1 billion. While at SCIMED, he was instrumental in guiding the company to be a major player in the cardiac angioplasty medical device market by achieving more than $300 million in sales by the time it was purchased by Boston Scientific.

After leaving SCIMED, Mr. Sullivan co-founded and served as president and CEO of anastomotic device-maker Vascular Science, Inc., which was sold to St. Jude Medical in 1999 for $95 million. Most recently, Mr. Sullivan co-founded Sinus Rhythm Technologies, Inc., a Minneapolis-based, development-stage company in cardiology, where he served as president and CEO.

Mr. Sullivan is an active company founder and board member of several medical device companies. A veteran medical industry leader, he co-founded Atritech, and sits on the board of NeuroVASxTM, Inc. He previously served on the board of Vascular Solutions, Quannum Medical, NeoVision, Inc. and ACIST Medical Systems, all companies that either completed a successful exit or an initial public offering.

Mr. Sullivan began his career at American Hospital Supply, Inc. He holds a bachelor’s degree in business and marketing from Arizona State University.